Indication

Primary malignant neoplasm of peritoneum

A primary malignant neoplasm of the peritoneum is a rare cancer that originates directly within the serous membrane lining the abdominal cavity and covering the abdominopelvic viscera, distinguishing it from secondary peritoneal carcinomatosis that metastasizes from other sites. Read more about Primary malignant neoplasm of peritoneum

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Primary malignant neoplasm of peritoneum therapies.

Showing 1–1 of 1 drugs

LIFYORLI (relacorilant)

GLUCOCORTICOID RECEPTOR ANTAGONISTS·MALIGNANT NEOPLASM OF FALLOPIAN TUBE·+2
CORCEPT THERAPE
Filter & compare in the drug finder →Opens the drug finder with Primary malignant neoplasm of peritoneum preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Primary malignant neoplasm of peritoneum.

A primary malignant neoplasm of the peritoneum is a rare cancer that originates directly within the serous membrane lining the abdominal cavity and covering the abdominopelvic viscera, distinguishing it from secondary peritoneal carcinomatosis that metastasizes from other sites.

The condition encompasses primary peritoneal carcinoma, which predominantly affects postmenopausal women and behaves identically to advanced epithelial ovarian cancer, as well as primary peritoneal malignant mesothelioma.

Pathophysiologically, it involves malignant transformation of peritoneal mesothelial or Müllerian-derived epithelial cells, frequently displaying diffuse sheet-like or nodular dissemination across peritoneal surfaces.

Patients typically present with advanced disease characterized by abdominal distension, ascites, diffuse abdominal discomfort, early satiety, and bowel habit alterations.

Personalize your experience

Follow Primary malignant neoplasm of peritoneum and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it